Cleared Traditional

PACER MODEL 100 INFUSION CONTROLLER (K963136) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
423d
Days
Class 2
Risk

K963136 is an FDA 510(k) clearance for the PACER MODEL 100 INFUSION CONTROLLER. Classified as Controller, Infusion, Intravascular, Electronic (product code LDR), Class II - Special Controls.

Submitted by Health Watch, Inc. (South West Ranches, US). The FDA issued a Cleared decision on October 10, 1997 after a review of 423 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Health Watch, Inc. devices

Submission Details

510(k) Number K963136 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1996
Decision Date October 10, 1997
Days to Decision 423 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
294d slower than avg
Panel avg: 129d · This submission: 423d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LDR Controller, Infusion, Intravascular, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LDR Controller, Infusion, Intravascular, Electronic

All 11
Devices cleared under the same product code (LDR) and FDA review panel - the closest regulatory comparables to K963136.
DEKA Infusion System, DEKA Administration Set
K242693 · Deka Research and Development Corporation · Oct 2024
DEKA Infusion System, DEKA Administration Set
K232316 · Deka Research and Development · Mar 2024
3M IV FLOW REGULATOR
K896907 · 3M Company · Feb 1990
LIFECARE 75 CONTROLLER
K893487 · Abbott Laboratories · Jul 1989
TECHNICON CHEM 1(TM) SYSTEM
K874916 · Technicon Instruments Corp. · Mar 1988
FLO-GARD 4000 VOLUMETRIC INFUSION CONTROLLER
K854863 · Travenol Laboratories, S.A. · Feb 1986